1413 / 1851
CONCLUSION: ABVD therapy alone improves the rate of long-term overall survival
in patients with stage IA or IIA nonbulky HL
Canadian HD6 trial
Meyer RM et al. NEJM 2012
!
|
|
1413 / 1851
CONCLUSION: ABVD therapy alone improves the rate of long-term overall survival
in patients with stage IA or IIA nonbulky HL
Canadian HD6 trial
Meyer RM et al. NEJM 2012
!